Quinine 600mg Tablet Franchise in Ahmedabad

Antimalarial & Fever Therapy Supplier in Mumbai

Quinshell 600 Tablet Distributor in Delhi

Malaria Treatment Tablet Franchise Opportunity in Bangalore

Antimalarial Tablet Stockist in Hyderabad
Quinine 600mg Export & Manufacturing in Chandigarh

Home/Products /quinine-600mg-tablet

Quinshell 600 Tablet

Composition : Quinine (600mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Quinshell 600 Tablet contains Quinine 600mg, an antimalarial agent indicated for the treatment of malaria and symptomatic relief of fever caused by Plasmodium species. It helps in rapidly reducing parasite load and managing high fever effectively.

Quinine works by interfering with the parasite’s hemoglobin metabolism, leading to the destruction of Plasmodium in the bloodstream. Its higher dose formulation ensures efficacy in moderate to severe malaria infections, both in adult and pediatric patients.

For distributors and healthcare suppliers, Quinshell 600 Tablet is a high-demand antimalarial therapy product, commonly supplied to hospitals, clinics, endemic regions, and government malaria control programs. Seasonal and endemic malaria incidence ensures consistent year-round demand.

Adding Quinshell 600 Tablet to your antimalarial therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, prescriber trust, and essential role in malaria treatment make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Quinshell 600 Tablet contains Quinine 600mg, an antimalarial agent indicated for the treatment of malaria and symptomatic relief of fever caused by Plasmodium species. It helps in rapidly reducing parasite load and managing high fever effectively.

Quinine works by interfering with the parasite’s hemoglobin metabolism, leading to the destruction of Plasmodium in the bloodstream. Its higher dose formulation ensures efficacy in moderate to severe malaria infections, both in adult and pediatric patients.

For distributors and healthcare suppliers, Quinshell 600 Tablet is a high-demand antimalarial therapy product, commonly supplied to hospitals, clinics, endemic regions, and government malaria control programs. Seasonal and endemic malaria incidence ensures consistent year-round demand.

Adding Quinshell 600 Tablet to your antimalarial therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, prescriber trust, and essential role in malaria treatment make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, headache, dizziness, or mild gastrointestinal discomfort. Rare but serious side effects include cardiac arrhythmias, severe hypersensitivity reactions, cinchonism (tinnitus, visual disturbances), or blood disorders. Patients should seek immediate medical attention if severe symptoms occur.

Quinshell 600 Tablet is indicated for the treatment of uncomplicated and severe malaria, especially due to Plasmodium falciparum, as prescribed by a healthcare professional. It may also be used as part of combination therapy according to local malaria treatment guidelines.

Quinshell 600 Tablet should be taken exactly as prescribed, and the full course must be completed to prevent malaria recurrence or drug resistance. Caution is advised in patients with heart conditions, liver or kidney impairment, or a history of hypersensitivity to quinine. Avoid alcohol and medications affecting heart rhythm during therapy.

Store Quinshell 600 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch